Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
about
Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptorsModeling of rifampicin-induced CYP3A4 activation dynamics for the prediction of clinical drug-drug interactions from in vitro dataIn vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrationsPharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year periodCethromycin: a promising new ketolide antibiotic for respiratory infections.Qualitative structure-metabolism relationships in the hydrolysis of carbamates.Nature nurtures the design of new semi-synthetic macrolide antibiotics.Predicting drug interaction potential with a physiologically based pharmacokinetic model: a case study of telithromycin, a time-dependent CYP3A inhibitor.Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages.Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
P2860
Q24606169-D06E9806-E21D-4D9D-BBE2-ECAB61EB0405Q28533793-FA8A0AB0-3B1B-4678-8D00-EFA7F9014D53Q33317067-C089BA0D-A364-4D5D-8DC6-B73F0EFD134DQ34932518-380ACCB3-ABDC-44FD-8C1A-3C7856884CE1Q37156289-583860FE-A331-4F69-96E5-62990CAE2F43Q37697782-2FC40872-13E3-4783-8F8B-06E7D7EC356BQ37742109-2635BA1B-03EA-42FA-B98B-3A0AD74FC11BQ39023947-D7FEEDFA-E578-4421-BFE1-53425B8E7173Q39643626-338DB44C-2F24-49C8-9360-025E30F14A38Q42932532-D66889EF-76D5-4496-93A3-2F964F7CAC1DQ45901623-94218BA8-A084-4192-A7DB-06B338AEAA72Q47119741-D3190270-C43A-485F-BC95-979C2514441BQ51100124-5584246B-649C-4093-A4AE-DEA81E7A8AB1
P2860
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@ast
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@en
type
label
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@ast
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@en
prefLabel
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@ast
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@en
P2093
P1476
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
@en
P2093
Guy Montay
Vijay O Bhargava
P304
P356
10.2165/00003088-200544090-00003
P577
2005-01-01T00:00:00Z
P5875
P6179
1033336638